Tricida, Inc. (TCDA)
| Market Cap | 198.58M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -264.79M |
| Shares Out | 50.03M |
| EPS (ttm) | -5.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $4.06 |
| Previous Close | $3.95 |
| Change ($) | 0.11 |
| Change (%) | 2.78% |
| Day's Open | 3.98 |
| Day's Range | 3.96 - 4.23 |
| Day's Volume | 238,884 |
| 52-Week Range | 3.74 - 32.99 |
Webcast Today at 4:30 pm Eastern Time Webcast Today at 4:30 pm Eastern Time
Webcast Today at 4:30 pm Eastern Time Webcast Today at 4:30 pm Eastern Time
SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2021 financial results after the close of market on Thu...
Tricida (TCDA) has been struggling lately, but the selling pressure may be coming to an end soon
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, Apr...
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candid...
After previously exiting a position in the fourth quarter of 2020, Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a new 5.03% stake in Tricida Inc. (NASDAQ:TCDA) earlier this...
NEW YORK, March 8, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class actio...
New York, New York--(Newsfile Corp. - March 8, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2...
New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) and certain of...
Los Angeles, California--(Newsfile Corp. - March 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tri...
New York, New York--(Newsfile Corp. - March 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...
New York, New York--(Newsfile Corp. - March 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...
Los Angeles, California--(Newsfile Corp. - March 5, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tr...
LOS ANGELES--(BUSINESS WIRE)---- $TCDA #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tricida, Inc. (TCDA)
NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...
New York, New York--(Newsfile Corp. - March 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...
LOS ANGELES, March 4, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 8, 2021 deadline to file a lead plaintiff motion in the class action filed on behal...
NEW YORK, March 3, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 and October...
New York, New York--(Newsfile Corp. - March 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...
New York, New York--(Newsfile Corp. - March 3, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...
Los Angeles, California--(Newsfile Corp. - March 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tr...
Extends Veverimer Patent Protection into 2038 Extends Veverimer Patent Protection into 2038
NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) and certain of its officers. ...
Investors with losses are encouraged to contact the firm before March 8, 2021; click here to submit trade information
New York, New York--(Newsfile Corp. - March 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tric...
New York, New York--(Newsfile Corp. - March 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that t...
New York, New York--(Newsfile Corp. - March 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tri...
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...
New York, New York--(Newsfile Corp. - February 27, 2021) - WHY: New York, N.Y., February 27, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...
The FDA denied the biotech's appeal, but there's still a path forward for its drug.
Tricida Inc (NASDAQ: TCDA) has received an Appeal Denied Letter (ADL) from the Office of New Drugs (OND) of the FDA in response to the company's Formal Dispute Resolution Request (FDRR) submitted in Dec...
New York, New York--(Newsfile Corp. - February 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Nationally-recognized securities law firm Block & Leviton LLP (www.blockleviton.com) announces that a lawsuit for violation of the federal securities laws has b...
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candida...
Tricida Has Received an Appeal Denied Letter from the Office of New Drugs of the FDA in Response to its Formal Dispute Resolution Request Tricida Has Received an Appeal Denied Letter from the Office of ...
LOS ANGELES, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 8 , 2021 deadline to file a lead plaintiff motion in the class action filed on...
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockh...
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class a...
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) and certain ...
NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 and Oct...
Los Angeles, California--(Newsfile Corp. - February 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. (...
New York, New York--(Newsfile Corp. - February 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging th...
NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded ...
New York, New York--(Newsfile Corp. - February 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...
New York, New York--(Newsfile Corp. - February 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. (NASDAQ: TCDA) ("Tricida" or the "Company") and certai...
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its fourth quarter and year-end 2020 financial results after the close of ...
BENSALEM, Pa., Feb. 22, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming March 8, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of invest...
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 an...
About TCDA
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jun 28, 2018 |
| CEO Gerrit Klaerner | Employees 64 |
| Stock Exchange NASDAQ | Ticker Symbol TCDA |
Analyst Forecasts
According to 4 analysts, the average rating for Tricida stock is "Buy." The 12-month stock price forecast is 15.33, which is an increase of 277.59% from the latest price.